ULOQ [Study As­sess­ment]

posted by Helmut Homepage – Vienna, Austria, 2017-10-30 11:30 (2362 d 16:07 ago) – Posting: # 17947
Views: 7,927

Hi Anand,

❝ In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?

❝ After Dilution also it found ULOQ.

❝ Method should be redeveloped or revalidated?


Perform a partial validation with a higher dilution. If passing the usual criteria for A&P, re-analyse the sample(s) with high concentrations.

❝ If included,What justification we should provide to Regulatory Agency?


IMHO, that’s not possible.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,669 registered users;
82 visitors (0 registered, 82 guests [including 9 identified bots]).
Forum time: 04:37 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5